American biopharmaceutical solutions company Syneos Health has invested an undisclosed amount in Indegene Omnipresence Inc., a subsidiary of Bengaluru-based healthtech firm Indegene, the company said.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in